MedPath

Acerus BioPharma Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

2

CANADA:1

Drug Approvals

NATESTO

Approval Date
May 6, 2016
CANADA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Evaluation of Testosterone Nasal Gel in Hypogonadal Boys

Phase 1
Terminated
Conditions
Hypogonadism
Interventions
First Posted Date
2017-11-17
Last Posted Date
2023-10-26
Lead Sponsor
Acerus Biopharma Inc.
Target Recruit Count
8
Registration Number
NCT03345797
Locations
🇬🇧

University of Glasgow, Royal Hospital for Children, Glasgow, Scotland, United Kingdom

🇬🇧

Cambridge University Hospital's NHS Foundation Trust, Cambridge, United Kingdom

🇬🇧

Alder Hey Children's Hospital, Liverpool, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.